🇺🇸 FDA
Pipeline program

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

PRO-QINF-3004

Phase 3 mab completed

Quick answer

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent for Seasonal Influenza is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Seasonal Influenza
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials